Patients with a presumptive diagnosis of an acute anaphylactoid reaction to anaesthesia were investigated to determine the cause of the reaction and the drug responsible by intradermal testing, patch and prick testing, sequential complement measurement, passive transfer testing and challenge. The most valuable information was provided by intradermal testing and a diagnosis could be made in 150 of 165 patients. When anaphylactoid reactions to anaesthetic drugs occur, intradermal testing one month after the reaction and sequential complement measurements in the immediate post reaction period will enable the diagnosis to be established in the majority of cases. Intradermal testing is of no value for trivial reactions or reactions to colloid solutions or contrast media.
neostigmine, 1: 1000 -local anaesthetics, 1 :100 A 1 mm wheal was raised on the forearm of the patient with each drug and control drugs, and repeated with a control patient or volunteer.
No patient was taking drugs which may interfere with response (steroids, sympathomimetics, antihistamines). Testing was carried out as close as possible to one month after the reaction.
A positive result was regarded as a wheal of greater than 1.0 cm which persisted for 30 minutes and was absent in controls. Where tests to more than one drug were positive, serial dilutions were used and positive results recorded for drugs which produced a wheal of greater than 1.0 cm with 1: 100,000 dilution.
The testing was used in three groups of patients: 1 Trivial Reactions. Fourteen patients were tested after reactions confined to the skin, or reactions resolving without treatment. 2 Preoperative. Nine patients with a history of "allergy to anaesthetics" and no clinical details available were tested preoperatively with the drugs to be given in the anaesthetic. (Patients with a history of severe vomiting after anaesthesia, which is often described by patients as "allergy", were not tested.) 3 Severe Reactions. One hundred and forty-two patients or histories were referred to the author over a period from 1972 to March 1981 after a history of a life-threatening reaction during anaesthesia. Intradermal testing was performed in 126 of these patients; 103 tests were performed by the author and 23 by the referring doctor. A number of departures from the protocol were necessary. Eighteen patients were tested four months or more after the reaction and one, four days after the reaction as it was felt (correctly) that she would not return for follow-up. One patient who reacted to propanidid given as sole agent was tested while on steroids as it was felt unethical to stop the steroids when the causative agent was known. In eight patients the tests were repeated two to four years after the first test.
Positive tests were regarded as confirmed if the drug was the sole agent used during the anaesthesia, passive transfer tests were positive, or subsequent anaesthesia using drugs with negative intradermal tests was uneventful. C. Challenge. Two patients were challenged with small intravenous doses of the drugs implicated in the reaction. D. Passive Transfer Tests. Serum was taken from 52 patients and stored at -30 cc. Prausnitz Kustner (PK) and Passive Cutaneous Anaphylaxis (PCA) tests were performed in 26 patients using a method previously des cri bed. 2 This method appeared to sensitise the monkeys and the intravenous challenge dose precipitated cardiac arrest and the method was changed to that described below. Macaca neminstrina monkeys were anaesthetised with ketamine 50 mg intramuscularly. The anterior abdominal wall was shaved and multiple injections of patient serum, and serum heated to 56 cC for two hours were injected intradermally.
At three hours and 24 hours the monkeys were given intravenous Evans blue dye and challenged by direct injection of 1 :50 dilutions of drugs implicated and control drugs into serum sites, control sites, and directly into the skin.
An area of blueing of greater than 5 mm occurring in four separate sites but absent from control sites, was regarded as a positive result. Because of the risk of capillary damage due to direct injection, multiple injections and sites were used. This method was used in 26 patients. E. Complement Changes. Sequential complement levels were performed within 24 hours post reaction in 27 patients. C3 and C4 were measured in 26 patients (total haemocytic complement), CH 50 in 11 patients, Clq in 8, Clq binding assay in 7. Fractions were measured by radial immunodiffusion with monospecific antigen. F. Patch and Prick Testing. Patch and prick testing were performed in 4 patients with positive intradermal tests. G. Evaluation of Methods. The methods were evaluated using formulae for diagnostic tests in un selected positions 3 • 4 as there is no conventional analysis for tests in a selected or at-risk group. This method is valid with three qualifications: 1. The prevalence figures refer only to the group studied, not the entire population. 2. Controls were excluded to make the population homogeneous. 3. As the likelihood of positive PK tests to ana~sthetic drugs and complement activation in eventful anaesthesia are low, the figures for specificity are unlikely to alter by increasing the size of the group. The formulae used are those of Habicht 3 : a = test positive: has disease b = te~t positive : no disease c = test negative: has disease d = test negative: no disease Specificity is the ability of the test to give a negative finding when the person tested has OC1 disease. 4 Sensitivity is the ability of the test to give a positive finding when the person tested has the disease. 4 Positive predictability is the likelihood that a subject with a positive test has the disease. 4 Negative predictability is the likelihood that a subject with a negative test does not have the disease. 4 Formulae: Specificity Sensitivity Positive predictability Negative predictability Prevalence of true
The results are calculated for PK tests, sequential complement changes, direct challenge, intradermal testing overall, and in intradermal testing in a selected group excluding reactions to colloids and contrast media. Trivial reactions have been excluded from analysis.
RESULTS
A. The dilution of drugs which produced wheal and flare reactions in volunteers is shown in Table 1 . Group 2 (Preoperative testing). Eight of the nine patients had negative tests and uneventful anaesthesia using the drugs tested. One patient had a positive test to alcuronium and uneventful anaesthesia with the drugs giving negative tests. Subsequently an anaphylactoid reaction during previous anaesthesia when alcuronium was used was confirmed.
Group 3 (Severe reactions). In 81 of the 126 patients intradermal testing was positive.
In 20 patients intradermal testing was negative and the history suggested alternative causes. Seventeen of these patients have had the same anaesthetic uneventfully on a subsequent occasion.
In 15 patients with a history highly suggestive of an anaphylactoid reaction, no diagnosis could be established. Four of these patients died and were not tested, and in 11 who received multiple drugs, intradermal tests were negative. Three of these patients had only large flare.reactions to one drug, which persisted in serial dilutions and were absent from controls. While not positive by the criteria of this series, they are possibly diagnostic as similar results which have been described in association with systemic features. 5 Four of the patients with negative tests were tested six months to two years after the reaction and one patient on radiotherapy and cytotoxic drugs demonstrated impaired responsiveness by a negative test to 1 : 10 dilutions of d-tubocurarine.
Three patients tested two to three years after reactions to Althesin had negative tests. Five patients tested three to four G. Evaluation. The results are shown in Table 4 . For all the tests, false negative results were more common than false positive results. The most valuable information as to the cause of a reaction was provided by intradermal testing.
Evaluation of tests to determine diagnosis of anaphylactoid reaction

DISCUSSION
Patients who undergo severe anaphylactoid reactions to drugs used in anaesthesia produce wheal and flare reactions to intradermal tests with a much greater dilution of the drugs responsible than patients who have no reaction, with the exception of colloid solutions and contrast media. Using the described protocol, reliable evidence of the nature of the reaction and the responsible drug can be determined, and with avoidance of this drug subsequent anaesthesia is safe. Intradermal testing appears of no use in minor reactions. Although the use of intradermal testing has been described as hazardous, suspicious and unreliable 6 -9 this study and many others supports its use. [10] [11] [12] [13] [14] [15] [16] [17] Although we found no positive intradermal tests with patients reacting to propranidid, one reaction was a convulsive type and one patient was on steroids when tested. Positive tests to propranidid have been described by others l7 and occurred in patients reacting to Althesin. Adkinson 18 (1980) states that intradermal testing under controlled conditions provides the most useful test for IgE antibody to drugs but warns that negative tests must be interpreted with caution as the patient may be allergic but not presented with the correct haptenic configuration of the drug. Systemic features (tachycardia and tightness in the chest rapidly responding to adrenaline) occurred in one patient in this series but more severe reactions have been noted by others. 5 • 14 The risk of intradermal testing appears small compared to the risk of a subsequent anaesthetic without adequate diagnosis. A second inherent advantage of intradermal testing over other tests is that it is simple and can be performed without laboratory facilities or experimental animals.
The possibility of cross sensitivity with relaxants, which has been confirmed in patients for alcuronium and d-tubocurarine and in one case with suxamethonium and gallamine, suggests that patients who react to one relaxant should be tested routinely for other relaxants. It Anaesthesia and Intensive Care, Vol. IX, No. 3, August, 1981 must be emphasised that the criteria of wheal size of greater than 1 cm is not absolute; smaller wheals may be diagnostic also, particularly if they persist.
The repeated tests suggest that sensitivity to Althesin may wane which has also been noted with propranidid. 17 Sensitivity to relaxants appears to persist and two patients had positive tests to relaxants at 8 and 20 years after the reactions. After a reaction to anaesthetic drugs intradermal testing is the absolute minimum investigation. 21
Passive Transfer Tests
Although more specific than an intradermal test, lack of sensitivity and poor negative predictive value, coupled with the technical difficulty, risk of hepatitis in humans and need for animal facilities limit the value of the tests and we concur with Clark that they add little to the value of intradermal testing. 22
Sequential Complement Conversion
The test is more specific than intradermal testing. Watkins has stated that in a large series he has not seen significant complement conversion in the absence of a systemic reaction. 23 The manner in which complement is activated is not known.24 All patients with classical activation had positive intradermal tests and nine of eleven had no previous exposure in contrast to Watkins' study}3 The limitations of this method are that it gives no indication as to the drug responsible 22 and has a low sensitivity. Further, it requires laboratory facilities or transport of frozen sera.
It does provide useful supplementary information and we believe sequential complement studies should be performed if the facility exists. The measurement of C3 conversion by electrophoresis has not been used in this series due to unavailability.
Challenge
Challenge as a diagnostic test is too dangerous for routine use.
Patch and Prick Testing
This study supports the view of Clark that the tests are useless with anaesthetic drugs. 22
Other Tests
Sequential changes in immunoglobulin levels have been used. 26 There are a number of objections to this form of testing. The immunoglobulins involved in the reaction are almost certainly bound to cells and not being measured and no data is available on changes in immunoglobulins during uneventful anaesthesia.
During a reaction the tests give no information about the drug responsible. Measuring immunoglobulin changes during challenge with the drug suspected may delineate the nature of the reaction but carries all the risks of challenge with the drug suspected. Leucocyte histamine release has been used to make the diagnosis. 15.16.27 This test is not routinely available, is tedious, requires large quantities of blood,22 and is dubious with histamine releasing drugs. 28 All the patients in the literature who have been investigated by this technique and who have had intradermal tests have had positive results from both. 15 . 16 Evans and colleagues investigated a patient who reacted during induction and found positive intradermal tests to thiopentone and not d-tubocurarine or suxamethonium. They showed positive leucocyte histamine release, selective binding of thiopentone to patient and not control sera, and cross sensitivity to methohexitone by antibody blocking studies. 29 Again, the sophisticated techniques confirmed the results of the simple skin test.
The manner in which application of alternative tests may lead to potential errors is illustrated by the case of a reaction on fifth exposure to thiopentone and first exposure to suxamethonium described by Baldwin. 41 The diagnosis was attributed to thiopentone because of previous exposure, evidence of immunoglobulin E changes, and complement conversion. This study shows that complement conversion may occur due to relaxants, and PK testing in this study and others ll • 31 confirm IgE involvement in reactions to relaxants. Most reactions to suxamethonium occur on first exposure. The reaction may well have been due to thiopentone but the investigations have provided as much information as tossing a coin. An intradermal test probably would have given the answer.
CONCLUSION
One month after anaphylactoid reactions to anaesthetic drugs, intradermal testing to all drugs used and drugs of similar structure should be performed. The measurement of sequential changes in complement or C3 conversion should be undertaken immediately after the reaction. There is no evidence that more sophisticated tests add information other than confirming intradermal tests. The increased safety of in vitro tests does not compensate for their reduced availability or technical difficulty. With all the tests used, positive results are of greater value than negative.
Tests involving intravenous challenge should not be used.
